e-learning
resources
Berlin 2008
Sunday, 05.10.2008
COPD - clinical and epidemiological aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increase in plasma alpha-linolenic acid is positively associated with lung function. The emphysema and cancer action program (EMCAP) study
S. Mesia-Vela, J. H. M. Austin, H. Campos, D. Yankelevitz, F. Ahmed, R. G. Barr (New York, NY, Boston, MA, Ithaca, NY, United States Of America)
Source:
Annual Congress 2008 - COPD - clinical and epidemiological aspects
Session:
COPD - clinical and epidemiological aspects
Session type:
Thematic Poster Session
Number:
1158
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Mesia-Vela, J. H. M. Austin, H. Campos, D. Yankelevitz, F. Ahmed, R. G. Barr (New York, NY, Boston, MA, Ithaca, NY, United States Of America). Increase in plasma alpha-linolenic acid is positively associated with lung function. The emphysema and cancer action program (EMCAP) study. Eur Respir J 2008; 32: Suppl. 52, 1158
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Aging decreases reversibility of pulmonary fibrosis by regulating PRDM16-related fatty acid metabolism in lung fibroblasts
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
The effect of conjugated linoleic acid supplementation on the nutritional status of COPD patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
The effect of dietary fatty acids on respiratory infection in human lung cells
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Higher plasma cholesterol and low density lipoproteins are associated with increased airway resistance in COPD
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015
Serum levels of hyaluronic acid are associated with COPD severity and predict survival
Source: Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018
Year: 2019
Loss of plasma phospholipid transfer protein (PLTP) activity enhances inflammatory responses to cigarette smoke in the lung
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
The lipokine, or palmitoleic acid (16:1), is a biomarker of lung function in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Increased METEORIN-LIKE (ML) expression promotes lung inflammation in asthma.
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis
Source: Eur Respir J 2007; 29: 958-964
Year: 2007
Decreased ant-oxidant capacity with fiber free diet during exposure to cigarette smoke was related with changes in proportion of cecal organic acids in mice
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013
The AIBAL study: increase in plasma and BAL levels of hyaluronic acid are associated with a risk of acute respiratory symptoms under work exposure in swine confinement units
Source: Eur Respir J 2001; 18: Suppl. 33, 112s
Year: 2001
The effects of conjugated linoleic acid supplementation on the serum levels of Interleukin-6 and Sirtuin-1 in COPD patients
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019
The effect of dietary fatty acids on inflammation in primary lung mesenchymal cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
Leptin levels are associated with reduced lung function in men with COPD
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Differential actions of the endogenous docosahexaenoic acid (DHA) electrophilic derivative 17-oxo-DHA in macrophages and bronchial epithelial cells
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007
LSC - 2020 - The transcriptome of IPF fibrotic foci identifies the fatty acid metabolism as a critical pathway in fibrogenesis
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept